This policy addresses the coverage for tumor markers only when utilized for the management of cancerous conditions. Tumor marker
![Premium Photo | Scientist holds blood sample for ca 50 blood test. a tumor marker for gastrointestinal malignancies. Premium Photo | Scientist holds blood sample for ca 50 blood test. a tumor marker for gastrointestinal malignancies.](https://img.freepik.com/premium-photo/scientist-holds-blood-sample-ca-50-blood-test-tumor-marker-gastrointestinal-malignancies_196584-530.jpg?w=360)
Premium Photo | Scientist holds blood sample for ca 50 blood test. a tumor marker for gastrointestinal malignancies.
![Tumor Markers in Pancreatic Cancer: A Comparative Clinical Study between CEA, CA 19-9 and CA 50 | Semantic Scholar Tumor Markers in Pancreatic Cancer: A Comparative Clinical Study between CEA, CA 19-9 and CA 50 | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f005295af4f24478cf0440a16a86437c025b6c6e/4-Table11-1.png)
Tumor Markers in Pancreatic Cancer: A Comparative Clinical Study between CEA, CA 19-9 and CA 50 | Semantic Scholar
![Tumor markers. All neoplastic markers (alpha fetoprotein; Carbohydrate... | Download Scientific Diagram Tumor markers. All neoplastic markers (alpha fetoprotein; Carbohydrate... | Download Scientific Diagram](https://www.researchgate.net/publication/335572236/figure/fig2/AS:799009841098753@1567510199512/Tumor-markers-All-neoplastic-markers-alpha-fetoprotein-Carbohydrate-Antigens-CA-199.png)
Tumor markers. All neoplastic markers (alpha fetoprotein; Carbohydrate... | Download Scientific Diagram
![Reagent Access® BR Monitor Tumor Marker Assay CA 15-3 For Access® Immunoassay Systems 2 X 50 Tests - Suprememed Reagent Access® BR Monitor Tumor Marker Assay CA 15-3 For Access® Immunoassay Systems 2 X 50 Tests - Suprememed](https://www.suprememed.com/wp-content/uploads/2022/02/bec387620bx2-595x595.jpg)
Reagent Access® BR Monitor Tumor Marker Assay CA 15-3 For Access® Immunoassay Systems 2 X 50 Tests - Suprememed
Tumor Markers Carbohydrate Antigens CA 19-9 and CA-50 and Carcinoembryonic Antigen in Pancreatic Cancer and Benign Diseases of t
![Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics](https://pubs.rsna.org/cms/10.1148/rg.2021210005/asset/images/medium/rg.2021210005.va.gif)
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
![Nomograms for predicting the prognostic value of serological tumor biomarkers in colorectal cancer patients after radical resection | Scientific Reports Nomograms for predicting the prognostic value of serological tumor biomarkers in colorectal cancer patients after radical resection | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fsrep46345/MediaObjects/41598_2017_Article_BFsrep46345_Fig1_HTML.jpg)
Nomograms for predicting the prognostic value of serological tumor biomarkers in colorectal cancer patients after radical resection | Scientific Reports
![Serum tumor markers (NSE, Ca 15–3, CEA, PSA, Ca 12–5, Ca 19–9) of 14... | Download Scientific Diagram Serum tumor markers (NSE, Ca 15–3, CEA, PSA, Ca 12–5, Ca 19–9) of 14... | Download Scientific Diagram](https://www.researchgate.net/publication/42255556/figure/fig3/AS:277343659675652@1443135289838/Serum-tumor-markers-NSE-Ca-15-3-CEA-PSA-Ca-12-5-Ca-19-9-of-14-patients-were.png)
Serum tumor markers (NSE, Ca 15–3, CEA, PSA, Ca 12–5, Ca 19–9) of 14... | Download Scientific Diagram
![The Innovation | Medicine on Twitter: "Commonly used Tumor Markers A tumor marker is a biomarker found in blood, urine, or body tissues that can be elevated by the presence of one The Innovation | Medicine on Twitter: "Commonly used Tumor Markers A tumor marker is a biomarker found in blood, urine, or body tissues that can be elevated by the presence of one](https://pbs.twimg.com/media/FdDwvxeXgAMJJDi.jpg)